Lv11
60 积分 2024-02-21 加入
Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension
3小时前
已完结
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
2个月前
已完结
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
4个月前
已完结
An Exploratory Trial of an Investigational RNA Therapeutic, IONIS-FB-LRx, for Treatment of IgA Nephropathy: New Interim Results
6个月前
已关闭
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)
6个月前
已完结
The first-in-human study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of the factor XI monoclonal antibody SHR-2004 in healthy subjects
9个月前
已关闭
Asundexian versus Apixaban in Patients with Atrial Fibrillation
9个月前
已完结
Therapeutic Potential of FXI Inhibitors: Hype or Hope?
9个月前
已完结
Phase 1 Trials of PNPLA3 siRNA in I148M Homozygous Patients with MAFLD
10个月前
已完结
miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay
1年前
已完结
皖公网安备34019202002308
